Page last updated: 2024-08-16

technetium tc 99m sestamibi and Bone Loss, Osteoclastic

technetium tc 99m sestamibi has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansquer, C; Drui, D; Gahier Penhoat, M; Guillot, P; Maugars, Y; Mirallie, E	1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Bone Loss, Osteoclastic

Article	Year
Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidism. Joint bone spine, 2017, Volume: 84, Issue:2 Topics: Adenoma; Aged; Biopsy; Bone Neoplasms; Bone Resorption; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi	2017

Article

Year

Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidism.

Joint bone spine, 2017, Volume: 84, Issue:2

Topics: Adenoma; Aged; Biopsy; Bone Neoplasms; Bone Resorption; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2017